Search results
Results from the WOW.Com Content Network
Ciclosporin is an experimental treatment for TSPK. It is usually used during transplants as it reduces the immune system response. Tacrolimus (Protopic 0.03% ointment) is also an experimental treatment. Laser eye treatment. [6] Amniotic membrane (Case Study) [7] PRK laser eye surgery has been suggested in a one-person case study as having cured ...
Conjunctivochalasis, also known as mechanical dry eye (MDE), is a common eye surface condition characterized by the presence of excess folds of the conjunctiva located between the globe of the eye and the eyelid margin.
A pterygium of the eye (pl.: pterygia or pterygiums, also called surfer's eye) is a pinkish, roughly triangular tissue growth of the conjunctiva onto the cornea of the eye. [2] It typically starts on the cornea near the nose. [3] It may slowly grow but rarely grows so large that it covers the pupil and impairs vision. [2] Often both eyes are ...
An amniotic membrane contact lens is made from the innermost layer of the placenta. It has regenerative and healing properties that help dry eye syndrome and corneal scarring, according to the ...
Trabeculectomy is a surgical procedure used in the treatment of glaucoma to relieve intraocular pressure by removing part of the eye's trabecular meshwork and adjacent structures. It is the most common glaucoma surgery performed and allows drainage of aqueous humor from within the eye to underneath the conjunctiva where it is absorbed.
Treatment includes artificial tears and eye lubricants, stopping toxic medications, performing punctal occlusion, bandage contact lens and amniotic membrane transplant. These measures intend to improve corneal epithelial healing.
These adhesions can, in rare cases, affect the motion of the eye and the desired alignment. [17] If scarring is extensive, it may be seen as raised and red tissue on the white of the eye. [4] Fibrosis reducing measures such as cryopreserved amniotic membrane and mitomycin C have been shown to have some utility during surgery. [17]
The projected benefits of maternal vaccination is the prevention of 899 cases of GBS disease and 35 deaths among infants. The cost savings in the prevention of GBS may be over 43 million dollars. Vaccination may be especially beneficial in low to middle income countries where screening and prophylactic treatment is not possible.